Is Formlabs profitable in 2026?

Formlabs does not disclose audited financials as a private company. Revenue estimates from data trackers range wildly, from about $82.5M to $750M, with ZoomInfo citing roughly $276.8M as of July 2026. No profitability figures are publicly confirmed.

Who is Formlabs' biggest competitor?

The most disruptive competitive threat cited by industry analysts is Bambu Lab, a Chinese low-cost desktop 3D printer maker whose shipments grew 64% year over year in Q1 2025, squeezing margins for 'low-cost providers like Bambu Labs and Formlabs' industry-wide.

Could AI replace Formlabs?

Unlikely to fully replace it. Formlabs' hardware manufacturing, proprietary resin/powder chemistry, and ISO 13485 medical certifications are AI-immune. Formlabs itself shipped an AI feature, 'Print Intelligence,' on its Fuse X1 printer launched June 9, 2026, using AI as a product differentiator rather than facing displacement.

What is Formlabs' current valuation?

Formlabs' last confirmed priced valuation was $2 billion from a $150M Series E led by SoftBank Vision Fund 2 in May 2021. A secondary-market tracker (TrueUp) estimated the valuation had fallen to roughly $0.7 billion as of June 2026, an unconfirmed markdown of about 65%.

Formlabs is privately held, founded in September 2011 by MIT Media Lab alumni Maxim Lobovsky, Natan Linder, and David Cranor. Its largest disclosed investor is SoftBank Vision Fund 2, which led the $150M Series E round in May 2021 at a $2B valuation.

What is the Fuse X1 and when does it ship?

The Fuse X1 is Formlabs' large-format industrial SLS 3D printer, announced June 9, 2026 and priced at $84,999. It features 13-zone Adaptive Thermal Control and an AI-powered 'Print Intelligence' anomaly detector. First customer deliveries are scheduled for Q4 2026.

Manufacturing companies · United States

Formlabs Inc.

formlabs.com ↗

Formlabs makes desktop resin and SLS 3D printers for professional, dental, and medical use.

Losing its protection

Assessed 24 July 2026 · Evidence as of 24 July 2026

The structural protection is eroding.

On the recordSince 24 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: Fuse X1 SLS line delivery and quality execution results

The call

Formlabs still leads certified dental and medical printing while cheaper rivals erode its broader market and its valuation sits frozen since 2021.

Formlabs makes 3D printers, especially for dentists and medical offices, where it holds certifications and relationships that are hard to replicate quickly. Its main vulnerability is Bambu Lab, a Chinese competitor selling much cheaper printers that work well enough for general professional use, which is already cutting into Formlabs' sales and profit margins. The question that will decide the company's future is whether the high-margin dental and medical business can stay protected while the broader market gets commoditized, and whether Formlabs can raise new funding without a steep down-round that crushes existing investor returns.

Why

AI pressure: None apparent. AI design tools could increase demand for prototyping but no AI agent replaces physical printer hardware here. Could AI do the core job? Unlikely.

Bigger players: Bambu Lab. Bambu Lab's cheap, fast printers are already squeezing margins in Formlabs' core professional and prosumer segment. Could a giant copy it? Probably.

What protects it. ISO 13485 certification, biocompatible materials, and regulated dental and medical distribution channels Bambu Lab has not entered.

What would change this call

Formlabs announces a new priced funding round with a stated valuation. Would show whether the 2021 $2B mark holds or a down-round confirms investor markdown.
Bambu Lab launches a certified dental or medical printing line. Would show the low-cost rival breaching Formlabs' one regulated, defensible moat.
Fuse X1 SLS system ships and reviews appear from dental/medical or industrial customers. Would show whether Formlabs can execute and hold its high-margin certified segment.

Key numbers

$150M Series E led by SoftBank at $2B valuation (May 2021)
Over 130,000 Formlabs printers deployed worldwide (2025-03-31)
Fuse SLS line held 55% of global SLS printer sales (2025)

Named risks

No priced funding round since May 2021; secondary estimates show ~65% valuation markdown to ~$0.7B. Severity: high
Bambu Lab and other low-cost Chinese entrants compressing margins in prosumer/professional segment. Severity: high
Revenue figures unverifiable across trackers, ranging $82.5M to $750M, undermining financial transparency. Severity: medium
Fuse X1 execution risk with first deliveries not scheduled until Q4 2026. Severity: medium
Industry consolidation among rivals (e.g., Nano Dimension acquiring Desktop Metal and Markforged) could reshape competitive field. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Bambu Lab	gaining on	Shipments up 64% YoY in Q1 2025, squeezing margins on low-cost providers like Formlabs
Stratasys	gaining on	Stratasys reported underwhelming Q4 2024 results while Formlabs' Fuse held 55% of SLS printer sales in 2025
3D Systems	gaining on	3D Systems posted underwhelming Q4 2024 results amid legacy-OEM pressure
Markforged	contesting	Direct composite-printer competitor, ~270 employees, ~$85M estimated revenue
SprintRay	contesting	Competes directly in dental 3D printing per Formlabs' own product comparison pages

Questions people ask

Is Formlabs profitable in 2026?: Formlabs does not disclose audited financials as a private company. Revenue estimates from data trackers range wildly, from about $82.5M to $750M, with ZoomInfo citing roughly $276.8M as of July 2026. No profitability figures are publicly confirmed.
Who is Formlabs' biggest competitor?: The most disruptive competitive threat cited by industry analysts is Bambu Lab, a Chinese low-cost desktop 3D printer maker whose shipments grew 64% year over year in Q1 2025, squeezing margins for 'low-cost providers like Bambu Labs and Formlabs' industry-wide.
Could AI replace Formlabs?: Unlikely to fully replace it. Formlabs' hardware manufacturing, proprietary resin/powder chemistry, and ISO 13485 medical certifications are AI-immune. Formlabs itself shipped an AI feature, 'Print Intelligence,' on its Fuse X1 printer launched June 9, 2026, using AI as a product differentiator rather than facing displacement.
What is Formlabs' current valuation?: Formlabs' last confirmed priced valuation was $2 billion from a $150M Series E led by SoftBank Vision Fund 2 in May 2021. A secondary-market tracker (TrueUp) estimated the valuation had fallen to roughly $0.7 billion as of June 2026, an unconfirmed markdown of about 65%.
Who owns Formlabs?: Formlabs is privately held, founded in September 2011 by MIT Media Lab alumni Maxim Lobovsky, Natan Linder, and David Cranor. Its largest disclosed investor is SoftBank Vision Fund 2, which led the $150M Series E round in May 2021 at a $2B valuation.
What is the Fuse X1 and when does it ship?: The Fuse X1 is Formlabs' large-format industrial SLS 3D printer, announced June 9, 2026 and priced at $84,999. It features 13-zone Adaptive Thermal Control and an AI-powered 'Print Intelligence' anomaly detector. First customer deliveries are scheduled for Q4 2026.

Timeline

2026-06-09Formlabs launches Fuse X1 industrial SLS printer at $84,999 with AI Print Intelligence
2024-10Formlabs launches Form 4L and Form 4BL large-format SLA printers
2024-08-15TechCrunch confirms Formlabs laid off fewer than 40 employees over prior two years
2024-07-11Formlabs acquires Micronics mid-Kickstarter campaign, refunds backers
2024-04Formlabs launches Form 4, its first LCD-based non-laser SLA printer
2023-10Report of roughly 14 layoffs at Formlabs
2021-05Formlabs raises $150M Series E led by SoftBank Vision Fund 2 at $2B valuation
2011-09Formlabs founded by Lobovsky, Linder, and Cranor at MIT Media Lab

Revision history

24 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Tesla Dow Goodyear Tire & Rubber